Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy

See Locations Near You

Summary

Optimal management of patients with locally advanced breast cancer remains a complex therapeutic problem. Newly diagnosed breast cancers in the United States with a higher incidence in medically underserved areas. The optimal intensity and duration of neoadjuvant chemotherapy still remains controversial due to the difficulty of evaluating response to therapy. The goal would be to prevent over and under treatment of patients with neoadjuvant chemotherapy.

View Full Description

Full Description

The Researcher developed a diagnostic device called Diffuse Optical Spectroscopy Imaging is a non-invasive optical technique that utilizes intensity-modulated, near-infrared light to quantitatively measure optical properties in thick tissues.

Diffuse Optical Spectroscopy Imaging can images tissue hemoglobin , oxygen saturation, blood volume fraction, water content, fat content and cellular structure. The measurements provide quantitative optical property values that reflect changes in tissue perfusion, oxygen consumption, and cell/matrix development.

There is no therapeutic benefit to the subject, especially none that might influence the indication for the diagnostic procedure as indicated. However, information obtained may lead to a new form of non-invasive imaging for the early detection of breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female non-pregnant and age greater than or equal to 21 years old but less than 75 years old
Diagnosed with breast cancer and will be receiving neoadjuvant chemotherapy

Exclusion Criteria:

Female pregnant and age less than 21 years old and have no diagnosis of breast cancer

Study is for people with:

Breast Cancer

Estimated Enrollment:

77

Study ID:

NCT00540852

Recruitment Status:

Completed

Sponsor:

University of California, Irvine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Beckman Laser Institute University Of California Irvine
Irvine California, 92612, United States
Chao Family Comprehensive Cancer Center
Orange California, 92868, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

77

Study ID:

NCT00540852

Recruitment Status:

Completed

Sponsor:


University of California, Irvine

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider